417 related articles for article (PubMed ID: 29704382)
1. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
Nadaraja RND; Sthaneshwar P; Razali N
Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
[TBL] [Abstract][Full Text] [Related]
3. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
4. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.
Al Kindi MK; Al Essry FS; Al Essry FS; Mula-Abed WA
Oman Med J; 2012 Nov; 27(6):471-4. PubMed ID: 23226817
[TBL] [Abstract][Full Text] [Related]
5. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
[TBL] [Abstract][Full Text] [Related]
6. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
Barth JH; Field HP; Yasmin E; Balen AH
Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
Chanukvadze D; Kristesashvili J
Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
[TBL] [Abstract][Full Text] [Related]
8. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH).
Chanukvadze D; Kristesashvili J; Kvashilava N
Iran J Reprod Med; 2012 Jul; 10(4):307-14. PubMed ID: 25246891
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
11. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
Yue CY; Lu LK; Li M; Zhang QL; Ying CM
PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
[TBL] [Abstract][Full Text] [Related]
12. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.
Pinola P; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Ruokonen A; Puukka K; Tapanainen JS; Morin-Papunen LC
J Clin Endocrinol Metab; 2015 Sep; 100(9):3400-7. PubMed ID: 26192874
[TBL] [Abstract][Full Text] [Related]
13. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
14. Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.
Pall ME; Lao MC; Patel SS; Lee ML; Ghods DE; Chandler DW; Friedman TC
Horm Metab Res; 2008 Nov; 40(11):813-8. PubMed ID: 18819057
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne.
Bansal P; Sardana K; Arora P; Khurana A; Garga UC; Sharma L
Dermatol Ther; 2020 Nov; 33(6):e13974. PubMed ID: 33185003
[TBL] [Abstract][Full Text] [Related]
16. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.
Cho LW; Kilpatrick ES; Jayagopal V; Diver MJ; Atkin SL
Clin Endocrinol (Oxf); 2008 Mar; 68(3):390-4. PubMed ID: 17888022
[TBL] [Abstract][Full Text] [Related]
17. The free androgen index is inaccurate in women when the SHBG concentration is low.
Keevil BG; Adaway J; Fiers T; Moghetti P; Kaufman JM
Clin Endocrinol (Oxf); 2018 May; 88(5):706-710. PubMed ID: 29405348
[TBL] [Abstract][Full Text] [Related]
18. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
Mueller A; Cupisti S; Binder H; Hoffmann I; Kiesewetter F; Beckmann MW; Dittrich R
Horm Res; 2007; 67(1):35-41. PubMed ID: 17019078
[TBL] [Abstract][Full Text] [Related]
19. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
Escobar-Morreale HF; Asunción M; Calvo RM; Sancho J; San Millán JL
Eur J Endocrinol; 2001 Nov; 145(5):619-24. PubMed ID: 11720881
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X
Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
